Precision medicine in diabetes prediction: Exploring a subgroup‐specific biomarker strategy for risk stratification
Journal of Diabetes Investigation · 2025
DOI: 10.1111/jdi.14311 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von I-Weng Yen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu County, Taiwan. Hauptthemen laut MEDLINE: Biomarkers, Diabetes Mellitus, Type 2, Precision Medicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
The early detection of high‐risk individuals is crucial to delay and reduce the incidence of type 2 diabetes. In this study, we aimed to explore the performance of a novel subgroup‐specific biomarker strategy in the prediction of incident diabetes. Materials and Methods In the Taiwan Lifestyle Cohort Study, adult subjects without diabetes were included and followed for the incidence of diabetes in 2006–2019. The biomarkers measured included blood secretogranin III (SCG3), vascular adhesion protein‐1 (VAP‐1), fibrinogen‐like protein 1 (FGL1), angiopoietin‐like protein 6 (ANGPTL6), and angiopoietin‐like protein 4 (ANGPTL4).
Results
Among the 1,287 subjects, 12.2% developed diabetes during a 6 year follow‐up. Blood VAP‐1 was significantly associated with incident diabetes in the overall population (HR = 0.724, P < 0.05), participants under 65 years old (HR = 0.685, P < 0.05), those with a BMI of ≥24 kg/m 2 (HR = 0.673, P < 0.05), and females (HR = 0.635, P < 0.05). Blood ANGPTL6 was significantly correlated with incident diabetes in participants aged 65 and older (HR = 0.314, P < 0.05), and blood SCG3 was associated with incident diabetes in those with a BMI of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu County, Taiwan.
- College of Medicine, Graduate Institute of Clinical Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Internal Medicine, Taipei City Hospital, Ren-Ai Branch, Taipei, Taiwan.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
- Department of Medical Imaging, E-DA Hospital, I-Shou University, Kaohsiung, Taiwan.
ORCID-Profile: Chia-Hung Lin, Chih-Yao Hsu, Hung-Yuan Li
Zitieren
APA
Yen, I. W., Chen, S. C., Lin, C. H., Fan, K. C., Yang, C. Y., Hsu, C. Y., Kuo, C. H., Lin, M. S., Lyu, Y. P., Juan, H. C., Heng-Huei, L., & Li, H. Y. (2025). Precision medicine in diabetes prediction: Exploring a subgroup‐specific biomarker strategy for risk stratification. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14311
Vancouver
Yen IW, Chen SC, Lin CH, Fan KC, Yang CY, Hsu CY, et al. Precision medicine in diabetes prediction: Exploring a subgroup‐specific biomarker strategy for risk stratification. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.14311
BibTeX
@article{Yen2025,
author = {Yen, I-Weng and Chen, Szu-Chi and Lin, Chia-Hung and Fan, Kang-Chih and Yang, Chung-Yi and Hsu, Chih-Yao and Kuo, Chun-Heng and Lin, Mao-Shin and Lyu, Ya-Pin and Juan, Hsien-Chia and Heng-Huei, Lin and Li, Hung-Yuan},
title = {Precision medicine in diabetes prediction: Exploring a subgroup‐specific biomarker strategy for risk stratification},
journal = {Journal of Diabetes Investigation},
year = {2025},
doi = {10.1111/jdi.14311}
}
EUVIMED